These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 25262963)
1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577 [TBL] [Abstract][Full Text] [Related]
2. Comparison of novel intrinsic versus conventional antitachycardia pacing for ventricular tachycardia among implantable cardioverter-defibrillator recipients. Yanagisawa S; Inden Y; Sato Y; Watanabe R; Goto T; Kondo S; Tachi M; Iwawaki T; Yamauchi R; Hiramatsu K; Shimojo M; Tsuji Y; Shibata R; Murohara T J Cardiovasc Electrophysiol; 2024 Apr; 35(4):821-831. PubMed ID: 38424678 [TBL] [Abstract][Full Text] [Related]
3. Optimization of anti-tachycardia pacing efficacy through scar-specific delivery and minimization of re-initiation: a virtual study on a cohort of infarcted porcine hearts. Qian S; Connolly A; Mendonca-Costa C; Campos F; Rodero C; Whitaker J; Rinaldi CA; Bishop MJ Europace; 2023 Feb; 25(2):716-725. PubMed ID: 36197749 [TBL] [Abstract][Full Text] [Related]
4. An in-silico assessment of efficacy of two novel intra-cardiac electrode configurations versus traditional anti-tachycardia pacing therapy for terminating sustained ventricular tachycardia. Qian S; Connolly A; Mendonca-Costa C; Campos F; Williams SE; Whitaker J; Rinaldi CA; Bishop MJ Comput Biol Med; 2021 Dec; 139():104987. PubMed ID: 34741904 [TBL] [Abstract][Full Text] [Related]
5. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy. Tsukahara K; Oginosawa Y; Fujino Y; Honda T; Kikuchi K; Nozoe M; Uchida T; Minamiguchi H; Sonoda K; Ogawa M; Ideguchi T; Kizaki Y; Nakamura T; Oba K; Higa S; Yoshida K; Yagyu K; Miyamoto T; Yamagishi Y; Ohe H; Kohno R; Kataoka M; Otsuji Y; Abe H J Arrhythm; 2021 Aug; 37(4):1052-1060. PubMed ID: 34386132 [TBL] [Abstract][Full Text] [Related]
6. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. Fang Y; Gu K; Yang B; Ju W; Chen H; Li M; Liu H; Wang J; Yang G; Chen M J Arrhythm; 2018 Feb; 34(1):36-45. PubMed ID: 29721112 [TBL] [Abstract][Full Text] [Related]
18. Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial. Lunati M; Defaye P; Mermi J; Garcia-Alberola A; Merino JL; Arenal A; Cappato R; Navarro X; Passardi M; Santini M Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S35-9. PubMed ID: 17169131 [TBL] [Abstract][Full Text] [Related]